Trade GALENICA N - GALE CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.35
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentCHF 1,000.00Overnight funding adjustmentCharges from full value of position-0.010838 %(-CHF 2.17)Trade size with leverage ~ CHF 20,000.00Money from leverage ~ $CHF 19,000.00Go to platform: -0.01084%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentCHF 1,000.00Overnight funding adjustmentCharges from full value of position-0.011384 %(-CHF 2.28)Trade size with leverage ~ CHF 20,000.00Money from leverage ~ $CHF 19,000.00Go to platform: -0.01138%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: CHF
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: Switzerland
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: CHF 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.010838 %
  (-CHF 2.17)

• Margin. Your investment: CHF 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.011384 %
  (-CHF 2.28)

Key Stats

• Prev. Close: 81.4
• Open: 80.85
• 1-Year Change: -5.55%
• Day's Range: 80.85 - 81.55

Trade GALENICA N - GALE

About Galenica AG

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Galenica AG revenues increased 10% to SF3.83B. Net income applicable to common stockholders decreased 3% to SF167.7M. Revenues reflect Products & Care segment increase of 14% to SF1.83B, Logistics & IT segment increase of 7% to SF2B, Other countries segment increase of 13% to SF30.6M. Net income was offset by Personnel costs increase of 17% to SF518.9M (expense).